Zauberman Howard I. 5
5 · COGENTIX MEDICAL INC /DE/ · Filed Mar 21, 2018
Insider Transaction Report
Form 5
Zauberman Howard I.
Interim CEO
Transactions
- Award
Stock Option (Right to Buy)
2015-02-02+20,000→ 20,000 totalExercise: $2.70From: 2015-02-02Exp: 2018-03-30→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]As a result of the merger between Uroplasty Inc. and Cogentix Medical, Inc., formerly Vision-Sciences, Inc. ("Cogentix"), the common stock of Cogentix split 1-for-5 resulting in a decrease in the number of options held by the reporting person. The reported option grant is adjusted to reflect the reverse split that occurred on March 31, 2015.
- [F2]The initial expiration date of the option grant was changed as a result of the merger.